UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults

Clinical infectious diseases, 2024-05, Vol.78 (5), p.1360-1368

2024

Volltextzugriff (PDF)

Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial

Clinical infectious diseases, 2024-10, Vol.79 (4), p.1088-1098

2024

Volltextzugriff (PDF)

Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age

Clinical infectious diseases, 2024-08, Vol.79 (4), p.1074-1084

2024

Volltextzugriff (PDF)

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Clinical infectious diseases, 2024-06, Vol.78 (6), p.1732-1744

2024

Volltextzugriff (PDF)

Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States

Clinical infectious diseases, 2024-05, Vol.78 (5), p.1328-1335

2024

Volltextzugriff (PDF)

We Have Effective Respiratory Syncytial Virus Vaccines to Prevent Disease in Adults: What Else Do We Need to Know About How to Use Them?

Clinical infectious diseases, 2024-10, Vol.79 (4), p.1099-1101

Branche, Angela R

2024

Volltextzugriff (PDF)

Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus

Clinical infectious diseases, 2010-05, Vol.50 (9), p.1258-1267

2010

Volltextzugriff (PDF)

Role of Neutralizing Antibodies in Adults With Community-Acquired Pneumonia by Respiratory Syncytial Virus

Clinical infectious diseases, 2012-04, Vol.54 (7), p.905-912

2012

Volltextzugriff (PDF)

Progress in the Development of Respiratory Syncytial Virus and Parainfluenza Virus Vaccines

Clinical infectious diseases, 2003-12, Vol.37 (12), p.1668-1677

2003

Volltextzugriff (PDF)

Influence of Maternal Antibodies on Neonatal Immunization against Respiratory Viruses

Clinical infectious diseases, 2001-11, Vol.33 (10), p.1720-1727

2001

Volltextzugriff (PDF)

Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the Literature

Clinical infectious diseases, 2008-02, Vol.46 (3), p.402-412

2008

Volltextzugriff (PDF)

Respiratory Syncytial Virus Infection and Disease in Infants and Young Children Observed from Birth in Kilifi District, Kenya

Clinical infectious diseases, 2008-01, Vol.46 (1), p.50-57

2008

Volltextzugriff (PDF)

Quantitative Effects of Palivizumab and Donor-Derived T Cells on Chronic Respiratory Syncytial Virus Infection, Lung Disease, and Fusion Glycoprotein Amino Acid Sequences in a Patient Before and After Bone Marrow Transplantation

Clinical infectious diseases, 2004-07, Vol.39 (2), p.e17-e20

2004

Volltextzugriff (PDF)

How Viral Sequence Analysis May Guide Development of Respiratory Syncytial Virus Monoclonal Antibodies

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e4409-e4410

2021

Volltextzugriff (PDF)

Maternal Immunization

Clinical infectious diseases, 1999-02, Vol.28 (2), p.219-224

1999

Volltextzugriff (PDF)

Respiratory Syncytial Virus Infection in Patients with Cancer: Still More Questions Than Answers

Clinical infectious diseases, 2008-06, Vol.46 (12), p.1933-1934

2008

Volltextzugriff (PDF)

Respiratory Viral Antigens in Autopsy Lung Tissue Specimens from Patients with Cancer or Myocardial Infarction

Clinical infectious diseases, 1999-08, Vol.29 (2), p.437-440

1999

Volltextzugriff (PDF)

Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes

Clinical infectious diseases, 2013-12, Vol.57 (12), p.1731-1741

2013

Volltextzugriff (PDF)

Medically Attended Respiratory Syncytial Virus Infections in Adults Aged ≥50 Years: Clinical Characteristics and Outcomes

Clinical infectious diseases, 2014-02, Vol.58 (3), p.342-349

2014

Volltextzugriff (PDF)

Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines

Clinical infectious diseases, 2017-09, Vol.65 (6), p.1020-1025

2017

Volltextzugriff (PDF)

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e4400-e4408

2021

Volltextzugriff (PDF)

High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections

Clinical infectious diseases, 2013-10, Vol.57 (8), p.1069-1077

2013

Volltextzugriff (PDF)

Respiratory Syncytial Virus Disease Severity in Young Children

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e4384-e4391

2021

Volltextzugriff (PDF)

Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies

Clinical infectious diseases, 2014-11, Vol.59 (suppl_5), p.S344-S351

2014

Volltextzugriff (PDF)

Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions

Clinical infectious diseases, 2024-01, Vol.78 (1), p.202-209

2024

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Infectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(159)
Mit Volltextzugriff
(159)

Publikationsform

Artikel
(159)

Sprache

Englisch
(159)

Erscheinungsjahr

n.n

Thema

Immunology
(159)
Infectious Diseases
(159)
Life Sciences & Biomedicine
(159)
Microbiology
(159)
Science & Technology
(159)
Humans
(146)
Respiratory Syncytial Virus
(89)
Infant
(70)
Viruses
(66)
Female
(64)
Male
(60)
Human Respiratory Syncytial Virus
(58)
Infections
(56)
Biological And Medical Sciences
(54)
Medical Sciences
(54)
Respiratory Syncytial Virus Infections - Epidemiology
(53)
Adult
(46)
Child
(44)
Child, Preschool
(42)
Viral Diseases
(40)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Oxford University Press Journals Current
(159)
Oxford Journals 2020 Medicine
(159)
EZB Free E-Journals
(159)
Journals@Ovid Complete
(159)
Single Journals
(159)
MEDLINE
(146)
JSTOR Complete Journals
(144)

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults

Safety and Immunogenicity of Respiratory Syncytial Virus Prefusion F Protein Vaccine when Co-administered with Adjuvanted Seasonal Quadrivalent Influenza Vaccine in Older Adults: A Phase 3 Randomized Trial

Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States

We Have Effective Respiratory Syncytial Virus Vaccines to Prevent Disease in Adults: What Else Do We Need to Know About How to Use Them?

Pharmacologic Advances in the Treatment and Prevention of Respiratory Syncytial Virus

Role of Neutralizing Antibodies in Adults With Community-Acquired Pneumonia by Respiratory Syncytial Virus

Progress in the Development of Respiratory Syncytial Virus and Parainfluenza Virus Vaccines

Influence of Maternal Antibodies on Neonatal Immunization against Respiratory Viruses

Respiratory Syncytial Virus Infection in Patients with Hematological Diseases: Single-Center Study and Review of the Literature

Respiratory Syncytial Virus Infection and Disease in Infants and Young Children Observed from Birth in Kilifi District, Kenya

Quantitative Effects of Palivizumab and Donor-Derived T Cells on Chronic Respiratory Syncytial Virus Infection, Lung Disease, and Fusion Glycoprotein Amino Acid Sequences in a Patient Before and After Bone Marrow Transplantation

How Viral Sequence Analysis May Guide Development of Respiratory Syncytial Virus Monoclonal Antibodies

Maternal Immunization

Respiratory Syncytial Virus Infection in Patients with Cancer: Still More Questions Than Answers

Respiratory Viral Antigens in Autopsy Lung Tissue Specimens from Patients with Cancer or Myocardial Infarction

Respiratory Syncytial Virus Lower Respiratory Disease in Hematopoietic Cell Transplant Recipients: Viral RNA Detection in Blood, Antiviral Treatment, and Clinical Outcomes

Medically Attended Respiratory Syncytial Virus Infections in Adults Aged ≥50 Years: Clinical Characteristics and Outcomes

Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants

High Morbidity and Mortality in Adults Hospitalized for Respiratory Syncytial Virus Infections

Respiratory Syncytial Virus Disease Severity in Young Children

Management of Respiratory Viral Infections in Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies

Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions

Aktive Filter

Suchergebnisse filtern